Research Article
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
Table 2
Clinicopathological characteristics of FUSCC PDAC patients stratified by MUC2 expression.
| Variables | MUC2 negative | MUC2 positive | |
| Age, (%) | | | 0.905 | <62 | 167 (47.0%) | 33 (47.8%) | | ≥62 | 188 (53.0%) | 36 (52.2%) | | Sex, (%) | | | 0.760 | Male | 201 (57.4%) | 41 (59.4%) | | Female | 149 (42.6%) | 28 (40.6%) | | Tumour grade, (%) | | | 0.171 | Low | 13 (3.7%) | 6 (8.7%) | | Moderate | 214 (61.3%) | 38 (55.1%) | | High | 122 (35.0%) | 25 (36.2%) | | Tumour stage, (%) | | | 0.699 | I | 143 (40.3%) | 26 (37.7%) | | II | 167 (47.0%) | 36 (52.2%) | | III | 45 (12.7%) | 7 (10.1%) | | T stage, (%) | | | 0.730 | T1 | 64 (18.0%) | 10 (14.5%) | | T2 | 204 (57.5%) | 40 (58.0%) | | T3 | 87 (24.5%) | 19 (27.5%) | | N stage, (%) | | | 0.746 | N0 | 182 (52.0%) | 33 (47.8%) | | N1 | 130 (37.1%) | 29 (42.0%) | | N2 | 38 (10.9%) | 7 (10.1%) | | Tumour location, (%) | | | 0.407 | Head | 191 (54.6%) | 39 (56.5%) | | Body | 158 (45.1%) | 29 (42.0%) | | Tail | 1 (0.3%) | 1 (1.4%) | | Vascular invasion, (%) | | | 0.830 | No | 92 (26.3%) | 19 (27.5%) | | Yes | 258 (73.7%) | 50 (72.5%) | | Perineural infiltration, (%) | | | 0.030 | No | 312 (89.1%) | 55 (79.7%) | | Yes | 38 (10.9%) | 14 (20.3%) | | Diabetes mellitus, (%) | | | 0.174 | No | 297 (84.9%) | 54 (78.3%) | | Yes | 53 (15.1%) | 15 (21.7%) | |
|
|